Friday, March 26, 2021

Common Alzheimer's treatment linked to slower cognitive decline

Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer's disease, but their effects on cognition have been debated and few studies have investigated their long-term effects. A new study shows persisting cognitive benefits and reduced mortality for up to five years after diagnosis.

from Healthy Aging News -- ScienceDaily https://ift.tt/3w1SpVM

No comments:

Post a Comment

Home